India’s Pharma Renaissance: Private Equity at the Helm

Indian pharmaceuticals have long been known as the “pharmacy of the world” — supplying affordable generics globally. But the industry is visibly pivoting: instead of volume-driven, low-margin generics alone, it’s embracing specialty drugs, branded portfolios, clinical platforms, and consolidated delivery ecosystems — and Private Equity (PE) is steering that shift. The recent news that Warburg…